Orthovita.com
PRODUCTS
COMPANY PROFILE
PATIENT INFORMATION
CAREERS
INVESTORS
CONTACT US
Skip Navigation LinksHome > Investors > Press Releases

Investors - Press Releases

Date PostedTitle
12/22/2009
Orthovita to Present at the J. P. Morgan 28th Annual Healthcare Conference
Subscribe to the Orthovita Press Release Alert service. As a subscriber, you will receive an e-mail alert whenever this type of company information is added to this Web site.

Earlier Releases

11/23/2009
Orthovita to Present at the Piper Jaffray 21st Annual Health Care Conference

11/13/2009
Orthovita to Participate in the Lazard Capital Markets 6th Annual Healthcare Conference

11/5/2009
Orthovita Reports 2009 Third Quarter Financial Results

11/4/2009
Orthovita to Host Investor Breakfast on Wednesday, November 11, 2009, in San Francisco, CA

10/23/2009
Orthovita Announces Presentation of Cortoss Clinical Study Results at the 2009 Congress of Neurological Surgeons Annual Meeting

10/22/2009
Orthovita Announces 2009 Third Quarter Sales

10/19/2009
Orthovita Schedules Third Quarter 2009 Financial Results Conference Call

9/15/2009
Orthovita to Participate in the UBS Global Life Sciences Conference

8/10/2009
Orthovita to Present at the Canaccord Adams Global Growth Conference

8/5/2009

7/27/2009
Orthovita Schedules Second Quarter 2009 Financial Results Conference Call

7/13/2009
New! Cortoss Pivotal IDE Study

6/8/2009
Orthovita Receives FDA Clearance for CORTOSS™ Bone Augmentation Material in Treatment of Vertebral Compression Fractures

6/2/2009
Orthovita Announces Upcoming VITOSS Bone Graft Substitute Presentations Scheduled for the 2009 American College of Spine Surgery Annual Meeting and the 2009 Global Spine Congress

5/18/2009
Nancy C. Broadbent to Join Orthovita as Senior Vice President and Chief Financial Officer

5/6/2009

4/23/2009
Orthovita Schedules First Quarter 2009 Financial Results Conference Call

4/1/2009
Orthovita Submits Additional Data to FDA in Support of its 510(k) Application for the Use of CORTOSS® Bone Augmentation Material in Vertebral Augmentation Two-Year Follow-Up Period Has Been Completed for Patients Enrolled in the CORTOSS Pivotal Study

3/18/2009
Orthovita to Participate in the Lazard Capital Markets Medical Technology Conference

3/11/2009

3/10/2009
Orthovita to Present at the Cowen and Company 29th Annual Health Care Conference

3/4/2009
Orthovita Board of Directors Elects William Tidmore Chairman of the Board

2/26/2009
Orthovita Schedules Fourth Quarter and Year-End 2008 Financial Results Conference Call

2/20/2009
Orthovita to Present at the Canaccord Adams Musculoskeletal Conference

2/13/2009
Orthovita to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

12/2/2008
Orthovita to Participate in the RBC Capital Markets 2008 Healthcare Conference

11/12/2008
Orthovita to Present at the Lazard Capital Markets 5th Annual Healthcare Conference

11/4/2008
Orthovita to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

11/3/2008

10/14/2008
Orthovita Schedules Third Quarter 2008 Financial Results Conference Call

9/22/2008
Orthovita Announces New VITOSS® Bioactive Foam Pack Bone Graft Substitute

9/18/2008
VITOSS Bone Graft Substitute Poster Presentation Scheduled for the 2008 CNS Annual Meeting

9/16/2008
Orthovita Files Response to FDA's Initial Review of the CORTOSS 510(k) Application

9/10/2008
Audio Webcast of Orthovita Presentation on September 22, 2008, at 9:30am ET, at the UBS 2008 Global Life Sciences Conference in New York

9/10/2008
Orthovita to Present at the 2008 UBS Global Life Sciences Conference in New York

8/8/2008
Orthovita to Present at the Canaccord Adams 28th Annual Global Growth Conference

8/6/2008
Orthovita Reports 2008 Second Quarter Financial Results

7/28/2008
Orthovita Schedules Second Quarter 2008 Financial Results Conference Call

6/3/2008
Orthovita to Present at the Needham & Company, LLC Seventh Annual Biotechnology and Medical Technology Conference

5/7/2008
Orthovita Reports 2008 First Quarter Financial Results

4/21/2008
Orthovita Schedules First Quarter 2008 Financial Results Conference Call

4/14/2008
Orthovita Introduces VITASURE™ Absorbable Hemostat as Part of its Strategy to Leverage its Biomaterials Sales Organization

3/18/2008
CORTOSS Podium Presentation at 2008 SIR Meeting

3/14/2008
Orthovita to Present at the Cowen and Company 28th Annual Health Care Conference

3/4/2008
Orthovita Announces New VITOSS® Bioactive Foam Bone Graft Substitute

3/3/2008
Orthovita Schedules Fourth Quarter and Year-End 2007 Financial Results Conference Call

2/29/2008 Orthovita to Present at Susquehanna Financial Group’s SIGnificant Options in Healthcare Conference

2/28/2008 Orthovita to Present at the Canaccord Adams Small-Cap Orthopedics Conference

2/26/2008 VITOSS Podium and Electronic Poster Presentations at 2008 AANS/CNS Meeting

2/20/2008 CORTOSS® Podium Presentation at 2008 ASSR Meeting

1/23/2008 Orthovita to Participate in the 2008 Wachovia Healthcare Conference

1/15/2008 Orthovita Submits 510(k) Application to FDA for the Use of CORTOSS® Bone Augmentation Material in Vertebral Augmentation